Boston Scientific (BSX) has an average rating of buy and mean price target of $62.35, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Capricor Therapeutics (CAPR) has an average rating of overweight and mean price target of $29.35, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $3.00, Change: $-3.57, Percent Change: -54.34%
Cincinnati Financial (CINF) has an average rating of overweight and mean price target of $190, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $179.11, Change: $-2.23, Percent Change: -1.23%
Wingstop (WING) has an average rating of buy and mean price target of $214.62, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)